FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
STAT3 |
|
106.000 |
Evidence |
|
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
106.000 |
Evidence |
|
CSK |
CSK: Tyrosine-protein kinase CSK |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
106.000 |
Evidence |
|
FER |
FER, TYK3: Proto-oncogene tyrosine-protein kinase FER |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
106.000 |
Evidence |
|
APS |
SH2B2, APS: SH2B adapter protein 2 |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
106.000 |
Evidence |
|
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
JAK1 |
|
106.000 |
Evidence |
|
TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
106.000 |
Evidence |
|
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
106.000 |
Evidence |
|
MYF5 |
MYF5: Myogenic factor 5 |
TAL2 |
TAL2: T-cell acute lymphocytic leukemia protein 2 |
106.000 |
Evidence |
|
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
106.000 |
Evidence |
|
CSK |
CSK: Tyrosine-protein kinase CSK |
STAT3 |
|
106.000 |
Evidence |
|
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
106.000 |
Evidence |
|
HAND1 |
HAND1, EHAND: Heart- and neural crest derivatives-expressed protein 1 |
TAL2 |
TAL2: T-cell acute lymphocytic leukemia protein 2 |
106.000 |
Evidence |
|
TAL2 |
TAL2: T-cell acute lymphocytic leukemia protein 2 |
TAL1 |
TAL1, SCL, TCL5: T-cell acute lymphocytic leukemia protein 1 |
106.000 |
Evidence |
|
TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
106.000 |
Evidence |
|
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
106.000 |
Evidence |
|
VAV1 |
VAV1, VAV: Proto-oncogene vav |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
106.000 |
Evidence |
|
PIK3R2 |
PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
106.000 |
Evidence |
|
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
106.000 |
Evidence |
|
STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
106.000 |
Evidence |
|
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
CSK |
CSK: Tyrosine-protein kinase CSK |
106.000 |
Evidence |
|
HCK |
IPI00029769 |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
106.000 |
Evidence |
|
STAT3 |
|
LYN |
LYN: Tyrosine-protein kinase Lyn |
106.000 |
Evidence |
|
CRKL |
CRKL: Crk-like protein |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
106.000 |
Evidence |
|
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
JAK1 |
|
106.000 |
Evidence |
|